[go: up one dir, main page]

ATA262587A - NEW NAPHTHALINE DERIVATIVES AND PHARMACEUTICALS CONTAINING THEM - Google Patents

NEW NAPHTHALINE DERIVATIVES AND PHARMACEUTICALS CONTAINING THEM

Info

Publication number
ATA262587A
ATA262587A AT262587A AT262587A ATA262587A AT A262587 A ATA262587 A AT A262587A AT 262587 A AT262587 A AT 262587A AT 262587 A AT262587 A AT 262587A AT A262587 A ATA262587 A AT A262587A
Authority
AT
Austria
Prior art keywords
new
pharmaceuticals containing
naphthaline derivatives
naphthaline
derivatives
Prior art date
Application number
AT262587A
Other languages
German (de)
Other versions
AT388372B (en
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Priority to AT262587A priority Critical patent/AT388372B/en
Publication of ATA262587A publication Critical patent/ATA262587A/en
Application granted granted Critical
Publication of AT388372B publication Critical patent/AT388372B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/14—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/12—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT262587A 1987-10-08 1987-10-08 Novel naphthalene derivatives and pharmaceuticals containing them AT388372B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT262587A AT388372B (en) 1987-10-08 1987-10-08 Novel naphthalene derivatives and pharmaceuticals containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT262587A AT388372B (en) 1987-10-08 1987-10-08 Novel naphthalene derivatives and pharmaceuticals containing them

Publications (2)

Publication Number Publication Date
ATA262587A true ATA262587A (en) 1988-11-15
AT388372B AT388372B (en) 1989-06-12

Family

ID=3537601

Family Applications (1)

Application Number Title Priority Date Filing Date
AT262587A AT388372B (en) 1987-10-08 1987-10-08 Novel naphthalene derivatives and pharmaceuticals containing them

Country Status (1)

Country Link
AT (1) AT388372B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR018699A1 (en) 1999-06-01 2001-11-28 Procter & Gamble METHOD FOR THE TREATMENT OF LOSS OF HAIR WHICH IS INCLUDED TO MANAGE A COMPOSITION THAT INCLUDES A COMPOUND WHICH DOES NOT AFFECT THE HEART
AR018698A1 (en) 1999-06-01 2001-11-28 Procter & Gamble METHOD FOR THE TREATMENT OF LOSS OF HAIR WHICH IS INCLUDED TO MANAGE A COMPOSITION THAT INCLUDES A COMPOUND WHICH DOES NOT AFFECT THE HEART
US6680344B1 (en) 1999-06-01 2004-01-20 The University Of Texas Southwestern Medical Center Method of treating hair loss using diphenylmethane derivatives
CA2766100C (en) 2009-06-29 2018-05-22 Incyte Corporation Pyrimidinones as pi3k inhibitors
WO2011075643A1 (en) 2009-12-18 2011-06-23 Incyte Corporation Substituted heteroaryl fused derivatives as pi3k inhibitors
WO2011075630A1 (en) 2009-12-18 2011-06-23 Incyte Corporation Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors
WO2011130342A1 (en) 2010-04-14 2011-10-20 Incyte Corporation FUSED DERIVATIVES AS ΡI3Κδ INHIBITORS
WO2011163195A1 (en) 2010-06-21 2011-12-29 Incyte Corporation Fused pyrrole derivatives as pi3k inhibitors
ES2764848T3 (en) 2010-12-20 2020-06-04 Incyte Holdings Corp N- (1- (substituted phenyl) ethyl) -9H-purine-6-amines as PI3K inhibitors
WO2012125629A1 (en) 2011-03-14 2012-09-20 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
US9126948B2 (en) 2011-03-25 2015-09-08 Incyte Holdings Corporation Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
KR102131612B1 (en) 2011-09-02 2020-07-08 인사이트 홀딩스 코포레이션 Heterocyclylamines as pi3k inhibitors
AR090548A1 (en) 2012-04-02 2014-11-19 Incyte Corp BICYCLIC AZAHETEROCICLOBENCILAMINS AS PI3K INHIBITORS
WO2015191677A1 (en) 2014-06-11 2015-12-17 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
SI3831833T1 (en) 2015-02-27 2023-03-31 Incyte Holdings Corporation Processes for the preparation of a pi3k inhibitor
WO2016183063A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Crystalline forms of a pi3k inhibitor
IL278889B2 (en) 2018-06-01 2025-11-01 Incyte Corp Dosage regimen for the treatment of PI3K-related disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO170760C (en) * 1985-01-10 1992-12-02 Tanabe Seiyaku Co ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE NAPHENSE DERIVATIVES

Also Published As

Publication number Publication date
AT388372B (en) 1989-06-12

Similar Documents

Publication Publication Date Title
DE3483713D1 (en) HYDROXYPYRIDONE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
DK229489A (en) PHARMACEUTICAL ORBATS
DE68929304D1 (en) Oligoribonucleotide derivatives and their use as antiviral drugs
FI871826A0 (en) Photochromic products and compounds
FI894611A7 (en) Granular pharmaceutical preparations
KR890004174U (en) Absorbent structures with gelling agents and absorbent products containing these structures
DK127787A (en) INTERLEUKIN-1ALFA DERIVATIVES AND MEDICINES CONTAINING SUCH DERIVATIVES
ATA262587A (en) NEW NAPHTHALINE DERIVATIVES AND PHARMACEUTICALS CONTAINING THEM
EG16349A (en) Novel organic compounds and their pharmaceutical use
DE68917499D1 (en) Catechol derivatives and pharmaceutical preparations containing them.
DE68926733D1 (en) Piperidine derivatives and hypotensives containing them
DK166355C (en) ADENOSIN DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH DERIVATIVES
DE3879617D1 (en) TRIPEPTIDE DERIVATIVES AND ANTIPLASMINE CONTAINERS THEREOF.
IT8922216A0 (en) PHARMACEUTICAL SOLUTION
DK674589D0 (en) BENZENE DERIVATIVES AND PROCEDURES FOR PROMOTING THEREFORE AND PHARMACEUTICAL AGENTS CONTAINING THE DERIVATIVES
DK143188A (en) PHARMACEUTICAL PREPARATIONS CONTAINING PYRANOQUINOLINE COMPOUNDS AND THEIR USE
DK162186D0 (en) AMINOKETON DERIVATIVES AND MEDICINALS CONTAINING SUCH DERIVATIVES
DK269289A (en) CYCLOPENTAND DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS
GR81223B (en) Organic compounds and their pharmaceutical use
DE3889426D1 (en) Tetraphenylthiophene derivatives and electrophotographic element containing them.
DK205590D0 (en) PHARMACEUTICAL NIFEDIPAL CONTAINER
GB2151228B (en) Organic compounds and their pharmaceutical use
IT1224244B (en) ANOREXIZING PHARMACEUTICAL COMPOSITION INCLUDING 5-IDROSSITRPOFANO
ZA892224B (en) Organic compounds and their pharmaceutical use
ATE70276T1 (en) BISPHOSPHONIC ACID DERIVATIVES AND PHARMACEUTICALS CONTAINING THEM.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee